Globus Medical Preps IPO, Sales Force Ramp Ahead Of Artificial Cervical Disc Approval
This article was originally published in The Gray Sheet
Firm files for initial public stock offering, awaits PMA approval of its Secure-C artificial cervical disc.
You may also be interested in...
Globus Medical goes public. Exact Sciences nets $57.8 million from stock sale for cancer test. Cleveland Heart gets $30 million for artificial heart development. More financings.
Investigational device exemption applications for total artificial disc systems should include plans for product durability testing and multi-center clinical trials with at least two years of follow-up, according to new FDA guidance
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.